JP6869653B2 - Absorbent article - Google Patents

Absorbent article Download PDF

Info

Publication number
JP6869653B2
JP6869653B2 JP2016131417A JP2016131417A JP6869653B2 JP 6869653 B2 JP6869653 B2 JP 6869653B2 JP 2016131417 A JP2016131417 A JP 2016131417A JP 2016131417 A JP2016131417 A JP 2016131417A JP 6869653 B2 JP6869653 B2 JP 6869653B2
Authority
JP
Japan
Prior art keywords
skin
vapor permeation
mass
absorbent
liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016131417A
Other languages
Japanese (ja)
Other versions
JP2018000546A (en
Inventor
典子 河北
典子 河北
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Priority to JP2016131417A priority Critical patent/JP6869653B2/en
Publication of JP2018000546A publication Critical patent/JP2018000546A/en
Application granted granted Critical
Publication of JP6869653B2 publication Critical patent/JP6869653B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Absorbent Articles And Supports Therefor (AREA)

Description

本発明は、生理用ナプキン、パンティライナ(おりものシート)、使い捨ておむつ等の吸収性物品に関する。 The present invention relates to absorbent articles such as sanitary napkins, pantyliners (pantyliners), disposable diapers and the like.

生理用ナプキン等の吸収性物品においては、吸収層に吸収された経血等の排泄液が、体温によって肌対向面側から蒸発して水蒸気として着用者の肌側に排出され、その排泄液の蒸散の結果、着用中の吸収性物品の内部空間(着用者の肌と吸収性物品の肌対向面との間)がムレた状態となり、それによって、かゆみ、カブレ等の肌トラブルが生じるおそれがある。そこで、肌トラブルの軽減、防止を目的とした吸収性物品が種々提案されている。 In absorbent articles such as sanitary napkins, the excretory liquid such as menstrual blood absorbed by the absorption layer evaporates from the skin facing surface side due to body temperature and is discharged as water vapor to the wearer's skin side. As a result of evaporation, the internal space of the absorbent article during wearing (between the wearer's skin and the skin facing surface of the absorbent article) becomes stuffy, which may cause skin troubles such as itching and rash. is there. Therefore, various absorbent articles have been proposed for the purpose of reducing and preventing skin troubles.

例えば特許文献1には、吸収性物品の肌対向面を形成する表面層の非肌対向面側に配された部材、例えば、表面層に接する直下のトランスファーシート、あるいは吸収層を包んでいるキャリアシート等に、ローションを塗工することが記載されており、また、ローション成分としてグリセリン等の多糖類を配合することも記載されている。特許文献1によれば、ローション加工を、吸収性物品の表面材やギャザーシート等の、着用者の肌に直接接触する面には施さずに、着用者の肌に直接接触しない面に施したことにより、着用時からローションが肌に付着せずに、液排泄時に滲み出してきたローションがカブレを軽減するとされている。 For example, Patent Document 1 describes a member arranged on the non-skin facing surface side of a surface layer forming a skin facing surface of an absorbent article, for example, a transfer sheet immediately below in contact with the surface layer, or a carrier wrapping the absorbing layer. It is described that a lotion is applied to a sheet or the like, and that a polysaccharide such as glycerin is blended as a lotion component. According to Patent Document 1, the lotion process is not applied to the surface material of the absorbent article, the gathered sheet, or the like that comes into direct contact with the wearer's skin, but is applied to the surface that does not come into direct contact with the wearer's skin. As a result, the lotion does not adhere to the skin from the time of wearing, and the lotion that has exuded during excretion of the liquid is said to reduce rash.

また特許文献2には、吸収性物品の脚部カフスの表面等、着用者の肌と直接接触する部位に、通常の接触、着用者の動き、体温により着用者の皮膚に移行可能なローションコーティングを施すことが記載されており、また、このローションコーティングに用いるローション組成物が、エモリエント及び該エモリエントのための固定化剤(グリセリンモノエステル等)を含むことも記載されている。 Further, Patent Document 2 describes a lotion coating that can be transferred to the wearer's skin by normal contact, wearer's movement, and body temperature on a part that comes into direct contact with the wearer's skin, such as the surface of a leg cuff of an absorbent article. It is also described that the lotion composition used for this lotion coating contains an emollient and an immobilizing agent for the emollient (such as glycerin monoester).

また特許文献3には、着用中における排泄液の蒸散を抑制し、ムレや肌トラブルを効果的に防止し得る吸収性物品として、表面層と吸収層との間にグリセリンを含む中間層が配された構成を有するものが記載されている。この中間層の具体例は、不織布にグリセリンを塗布した繊維シートであり、該繊維シートは、着用時に着用者の排泄部(膣口等)に対向配置される領域において、表面層と吸収層を構成するコアラップシートとの間に配される。特許文献3によれば、着用者から排泄された排泄液が中間層にてグリセリンと混ざり合うことによって、排泄液の肌側への蒸散が抑制されると共に、排泄液の吸収が促進され、さらに表面層側への液戻りが抑制されるとされている。 Further, in Patent Document 3, an intermediate layer containing glycerin is arranged between the surface layer and the absorbent layer as an absorbent article capable of suppressing transpiration of excrement liquid during wearing and effectively preventing stuffiness and skin troubles. Those having the above-mentioned configuration are described. A specific example of this intermediate layer is a fiber sheet in which glycerin is applied to a non-woven fabric, and the fiber sheet has a surface layer and an absorption layer in a region facing the excretory part (vaginal opening, etc.) of the wearer when worn. It is arranged between the core wrap sheet and the constituent core wrap sheet. According to Patent Document 3, the excrement liquid excreted from the wearer is mixed with glycerin in the intermediate layer, so that the evaporation of the excrement liquid to the skin side is suppressed and the absorption of the excrement liquid is promoted, and further. It is said that liquid return to the surface layer side is suppressed.

特開2004−89322号公報Japanese Unexamined Patent Publication No. 2004-89322 特開2001−314440号公報Japanese Unexamined Patent Publication No. 2001-314440 特開2015−104646号公報Japanese Unexamined Patent Publication No. 2015-104646

特許文献1及び2記載技術は、吸収性物品着用中のムレに起因する肌トラブルを軽減するために、吸収性物品の着用中にローション成分が着用者の肌に移行するように構成するというものであり、特許文献3記載技術のような、肌トラブルの原因となるムレや排泄液の蒸散を抑制する技術ではない。特許文献3記載技術は、吸収性物品着用中のムレや排泄液の蒸散の抑制に一定の効果はあるものの、改善の余地はある。また、この種の吸収性物品においては、吸収層に吸収された排泄物に起因する不快臭、特に経血や膣排泄物に起因する不快臭が、着用中においては着用者の周辺に拡散し、使用済みの吸収性物品を廃棄した後においてはその廃棄場所の周辺に拡散するという課題があるが、特許文献1〜3には斯かる課題を解決し得る手段は記載されていない。 The techniques described in Patent Documents 1 and 2 are configured such that the lotion component is transferred to the wearer's skin while wearing the absorbent article in order to reduce skin troubles caused by stuffiness while wearing the absorbent article. Therefore, it is not a technique for suppressing stuffiness and evaporation of excrement liquid that cause skin troubles, as in the technique described in Patent Document 3. Although the technique described in Patent Document 3 has a certain effect on suppressing stuffiness and transpiration of excrement liquid while wearing an absorbent article, there is room for improvement. Further, in this type of absorbent article, an unpleasant odor caused by excrement absorbed in the absorption layer, particularly an unpleasant odor caused by menstrual blood or vaginal excrement, diffuses around the wearer during wearing. After disposing of the used absorbent article, there is a problem that it diffuses around the disposal site, but Patent Documents 1 to 3 do not describe a means capable of solving such a problem.

従って本発明の課題は、着用中において排泄液の蒸散を抑制し、ムレや肌トラブルを効果的に防止し得る吸収性物品を提供することに関する。 Therefore, an object of the present invention is to provide an absorbent article capable of suppressing evaporation of excrement liquid during wearing and effectively preventing stuffiness and skin troubles.

本発明は、肌対向面を形成する液透過性の表面層、非肌対向面を形成する液不透過性の防漏層、及び両層間に介在され、着用者の排泄液を吸収する吸収層を具備する吸収性物品であって、前記吸収層は蒸気透過抑制剤を含有し、前記蒸気透過抑制剤は、油分、乳化剤及びゲル化剤を含有する吸収性物品である。 In the present invention, a liquid-permeable surface layer forming a skin-facing surface, a liquid-impermeable leak-proof layer forming a non-skin-facing surface, and an absorption layer intervening between both layers to absorb the wearer's excrement. The absorbent layer contains a vapor permeation inhibitor, and the vapor permeation inhibitor is an absorbent article containing an oil, an emulsifier, and a gelling agent.

本発明によれば、着用中において排泄液の蒸散を抑制し、ムレや肌トラブルを効果的に防止し得る吸収性物品が提供される。この排泄液の蒸散を抑制する機能を有する前記蒸気透過抑制剤は、表面層よりも着用者の肌から遠い位置に配される吸収層中に含有されているため、該蒸気透過抑制剤が着用者の肌と接触する不都合が発生し難い。また、本発明の吸収性物品によれば、前記蒸気透過抑制剤の作用により、吸収層に吸収された排泄物由来の不快臭が表面層側から外部に拡散する不都合の防止効果が期待できる。 According to the present invention, there is provided an absorbent article capable of suppressing evaporation of excrement liquid during wearing and effectively preventing stuffiness and skin troubles. Since the vapor permeation inhibitor having a function of suppressing the evaporation of the excrement liquid is contained in the absorption layer arranged at a position farther from the wearer's skin than the surface layer, the vapor permeation inhibitor is worn. The inconvenience of contacting a person's skin is unlikely to occur. Further, according to the absorbent article of the present invention, the action of the vapor permeation inhibitor can be expected to have an effect of preventing the inconvenience that the unpleasant odor derived from excrement absorbed in the absorption layer diffuses from the surface layer side to the outside.

図1は、本発明の吸収性物品の一実施形態である生理用ナプキンの肌対向面側(表面層側)を一部破断して示す平面図である。FIG. 1 is a plan view showing a part of the skin-facing surface side (surface layer side) of the sanitary napkin according to the embodiment of the absorbent article of the present invention. 図2は、図1のI−I線断面を模式的に示す断面図である。FIG. 2 is a cross-sectional view schematically showing a cross section taken along line II of FIG. 図3は、図1に示す生理用ナプキンにおける蒸気透過抑制剤の作用効果の説明図である。FIG. 3 is an explanatory diagram of the action and effect of the vapor permeation inhibitor in the sanitary napkin shown in FIG.

以下、本発明の吸収性物品を、その好ましい実施形態に基づき図面を参照して説明する。図1及び図2には、本発明の吸収性物品の一実施形態である生理用ナプキンが示されている。本実施形態のナプキン1は、肌対向面を形成する液透過性の表面層としての表面シート2、非肌対向面を形成する液不透過性の防漏層としての裏面シート3、及び両層2,3間に介在され、着用者が排泄した経血等の排泄液を吸収する吸収層としての吸収体4を具備する。 Hereinafter, the absorbent article of the present invention will be described with reference to the drawings based on its preferred embodiment. 1 and 2 show a sanitary napkin, which is an embodiment of the absorbent article of the present invention. The napkin 1 of the present embodiment includes a surface sheet 2 as a liquid-permeable surface layer forming a skin-facing surface, a back surface sheet 3 as a liquid-impermeable leak-proof layer forming a non-skin-facing surface, and both layers. It is provided with an absorber 4 as an absorbing layer that is interposed between a few and absorbs excreted liquid such as menstrual blood excreted by the wearer.

本明細書において、肌対向面は、吸収性物品又はその構成部材(例えば吸収体4)における、吸収性物品の着用時に着用者の肌側に向けられる面、即ち相対的に着用者の肌に近い側であり、「非肌対向面」は、吸収性物品又はその構成部材における、吸収性物品の着用時に肌側とは反対側、即ち相対的に着用者の肌から遠い側に向けられる面である。尚、ここでいう「着用時」は、通常の適正な着用位置、即ち当該吸収性物品の正しい着用位置が維持された状態を意味し、吸収性物品が該着用位置からずれた状態にある場合は含まない。 In the present specification, the skin-facing surface is a surface of the absorbent article or a component thereof (for example, the absorber 4) that is directed toward the wearer's skin when the absorbent article is worn, that is, relatively on the wearer's skin. The near side, the "non-skin facing surface", is the surface of the absorbent article or its constituents that faces the side opposite to the skin side when the absorbent article is worn, that is, the side that is relatively far from the wearer's skin. Is. In addition, "when worn" here means a state in which the normal proper wearing position, that is, the correct wearing position of the absorbent article is maintained, and the absorbent article is in a state deviated from the wearing position. Does not include.

ナプキン1は、表面シート2、裏面シート3及び吸収体4を具備する吸収性本体5を備えている。ナプキン1又は吸収性本体5は、図1に示すように、着用者の腹側から股間部を介して背側に延びる縦方向Xとこれに直交する横方向Yとを有する。縦方向Xは、ナプキン1又は吸収性本体5の長手方向に一致し、横方向Yは、ナプキン1又は吸収性本体5の幅方向に一致する。表面シート2及び裏面シート3は、それぞれ、吸収体4よりも大きな寸法を有し、吸収体4の周縁から外方に延出し、それらの延出部において、接着剤、ヒートシール、超音波シール等の公知の接合手段によって互いに接合されて周縁シール部6を形成している。表面シート2及び裏面シート3と吸収体4との間は接着剤によって接合されていても良い。 The napkin 1 includes an absorbent body 5 including a front surface sheet 2, a back surface sheet 3, and an absorber 4. As shown in FIG. 1, the napkin 1 or the absorbent body 5 has a vertical direction X extending from the ventral side of the wearer to the dorsal side via the crotch portion and a lateral direction Y orthogonal to the vertical direction X. The vertical direction X corresponds to the longitudinal direction of the napkin 1 or the absorbent body 5, and the horizontal direction Y corresponds to the width direction of the napkin 1 or the absorbent body 5. The front surface sheet 2 and the back surface sheet 3 each have a larger size than the absorber 4, and extend outward from the peripheral edge of the absorber 4, and at the extending portion thereof, an adhesive, a heat seal, and an ultrasonic seal are used. The peripheral seal portion 6 is formed by being bonded to each other by a known bonding means such as. The front surface sheet 2 and the back surface sheet 3 and the absorber 4 may be bonded by an adhesive.

ナプキン1又は吸収性本体5は、着用時に着用者の股間部に配される股下部1Mと、該股下部1Mよりも着用者の腹側即ち前側に配される前方部1Fと、該股下部1Mよりも着用者の背側即ち後側に配される後方部1Rとを縦方向Xに有する。股下部1Mは、ナプキン1の着用時に着用者の股間部における排泄部(膣口等)に対向配置される排泄部対向部を有し、排泄部対向部は通常、股下部1Mにおける横方向Yの中央部に位置する。 The napkin 1 or the absorbent body 5 has a crotch part 1M arranged in the crotch part of the wearer at the time of wearing, a front part 1F arranged on the ventral side, that is, the front side of the wearer from the crotch part 1M, and the crotch part. The rear portion 1R arranged on the back side, that is, the rear side of the wearer with respect to 1M is provided in the vertical direction X. The inseam 1M has an excretion portion facing portion that is arranged to face the excretion portion (vaginal opening, etc.) in the wearer's crotch portion when the napkin 1 is worn, and the excretion portion facing portion is usually laterally Y in the inseam 1M. Located in the center of.

吸収体4は、吸収性材料を含有する吸収性コア40と、該吸収性コア40の外面即ち肌対向面及び非肌対向面を被覆するコアラップシート41とを含んで構成されている。吸収性コア40は単層構造であり、図1に示す如き平面視において縦方向Xに長い略矩形形状をなし、前方部1Fから後方部1Rに亘って延在している。コアラップシート41は、吸収性コア40の横方向Yの長さの2倍以上3倍以下の幅を有する1枚の連続した液透過性シートであり、図2に示すように、吸収性コア40の肌対向面の全域を被覆し、且つ吸収性コア40の縦方向Xに沿う両側縁から横方向Yの外方に延出し、その延出部が、吸収性コア40の下方に巻き下げられて、吸収性コア40の非肌対向面の全域を被覆している。尚、コアラップシートはこのような1枚のシートでなくても良く、例えば、吸収性コア40の肌対向面を被覆する1枚の肌側コアラップシートと、該肌側コアラップシートとは別体で、吸収性コア40の非肌対向面を被覆する1枚の非肌側コアラップシートとを含んで構成されていても良い。吸収性コア40とコアラップシート41との間は、ホットメルト型接着剤等の公知の接合手段により接合されていても良い。吸収性コア40としては、この種の吸収性物品に通常用いられるものであれば特に制限なく用いることができ、例えば、木材パルプ、親水化処理された合繊繊維等の繊維集合体、又は該繊維集合体に粒子状の吸水性ポリマーを保持させたもの等を用いることができる。コアラップシート41としては、例えば、紙、各種不織布、開孔フィルム等の液透過性シートを用いることができる。 The absorber 4 includes an absorbent core 40 containing an absorbent material and a core wrap sheet 41 that covers the outer surface of the absorbent core 40, that is, the skin-facing surface and the non-skin-facing surface. The absorbent core 40 has a single-layer structure, has a substantially rectangular shape long in the vertical direction X in a plan view as shown in FIG. 1, and extends from the front portion 1F to the rear portion 1R. The core wrap sheet 41 is one continuous liquid permeable sheet having a width of 2 times or more and 3 times or less the length of the lateral Y of the absorbent core 40, and as shown in FIG. 2, the absorbent core is It covers the entire skin-facing surface of the 40 and extends outward in the lateral direction Y from both side edges along the vertical direction X of the absorbent core 40, and the extending portion is wound down below the absorbent core 40. It covers the entire non-skin facing surface of the absorbent core 40. The core wrap sheet does not have to be such a single sheet. For example, one skin-side core wrap sheet that covers the skin-facing surface of the absorbent core 40 and the skin-side core wrap sheet are Separately, it may be configured to include one non-skin side core wrap sheet that covers the non-skin facing surface of the absorbent core 40. The absorbent core 40 and the core wrap sheet 41 may be joined by a known joining means such as a hot melt type adhesive. The absorbent core 40 can be used without particular limitation as long as it is usually used for this kind of absorbent article. For example, a fiber aggregate such as wood pulp, a hydrophilized synthetic fiber, or the fiber. An aggregate in which a particulate water-absorbent polymer is retained can be used. As the core wrap sheet 41, for example, a liquid permeable sheet such as paper, various non-woven fabrics, and perforated films can be used.

表面シート2及び裏面シート3は、吸収体4の縦方向Xに沿う両側縁それぞれから横方向Yの外方に延出してサイドフラップ部を形成し、該サイドフラップ部は、股下部1Mにおいて周辺部(前方部1F及び後方部1R)よりも横方向Yの外方に張り出し、これにより吸収性本体5の股下部1Mにおける縦方向Xに沿う左右両側に、一対のウイング部7,7が延設されている。ウイング部7は、ナプキン1をショーツ等の着衣のクロッチ部に固定する際に、着衣の非肌対向面側に折り返されて使用される。 The front surface sheet 2 and the back surface sheet 3 extend outward in the lateral direction Y from each of the side edges of the absorber 4 along the vertical direction X to form a side flap portion, and the side flap portion is peripheral at the inseam 1M. A pair of wing portions 7 and 7 extend outward in the lateral direction Y from the portions (front portion 1F and rear portion 1R), thereby extending the pair of wing portions 7 and 7 on both the left and right sides along the vertical direction X in the crotch lower portion 1M of the absorbent body 5. It is installed. The wing portion 7 is used by being folded back toward the non-skin facing surface side of the clothing when the napkin 1 is fixed to the crotch portion of the clothing such as shorts.

吸収性本体5の非肌対向面即ち裏面シート3の非肌対向面には、図2に示すように、ナプキン1をショーツ等の着衣に固定する本体粘着部8が設けられている。また、ウイング部7の非肌対向面即ち裏面シート3の非肌対向面には、ウイング部7をショーツ等の着衣に固定するウイング部粘着部9が設けられている。両粘着部8,9は、不使用時には剥離シート(図示せず)によって被覆されている。 As shown in FIG. 2, a main body adhesive portion 8 for fixing the napkin 1 to clothes such as shorts is provided on the non-skin facing surface of the absorbent main body 5, that is, the non-skin facing surface of the back sheet 3. Further, on the non-skin facing surface of the wing portion 7, that is, the non-skin facing surface of the back sheet 3, a wing portion adhesive portion 9 for fixing the wing portion 7 to clothes such as shorts is provided. Both adhesive portions 8 and 9 are covered with a release sheet (not shown) when not in use.

本発明の吸収性物品の主たる特徴の1つとして、吸収層が蒸気透過抑制剤を含有している点が挙げられる。この蒸気透過抑制剤は、経血、尿等の排泄液との接触により該排泄液由来の蒸気の表面層側への透過を抑制する機能(排泄液蒸散抑制機能)を発現する剤であり、油分、乳化剤及びゲル化剤を含有する。本実施形態のナプキン1においては図2に示すように、符号10で示す蒸気透過抑制剤は、吸収性コア40の肌対向面(表面シート2側の面)とコアラップシート41との間に存している。 One of the main features of the absorbent article of the present invention is that the absorbent layer contains a vapor permeation inhibitor. This vapor permeation inhibitor is an agent that exhibits a function of suppressing the permeation of vapor derived from the excrement liquid to the surface layer side (excretion liquid evaporation suppression function) by contact with excretion liquid such as menstrual blood and urine. Contains oil, emulsifier and gelling agent. In the napkin 1 of the present embodiment, as shown in FIG. 2, the vapor permeation inhibitor represented by reference numeral 10 is placed between the skin-facing surface (the surface on the surface sheet 2 side) of the absorbent core 40 and the core wrap sheet 41. Exists.

本発明に係る蒸気透過抑制剤は、典型的には、排泄液との接触前は常温常圧下において粉末状であり、この状態では排泄液蒸散抑制機能を有していないが、経血、尿等の排泄液と接触すると該排泄液中に溶解又は分散して排泄液蒸散抑制機能を発現し、該排泄液中の水分が蒸発して表面層側さらには着用者の肌側へ透過する不都合を抑制し得る。例えばナプキン1の着用中において、経血等の排泄液が着用者の排泄部から股下部1Mの前記排泄部対向部即ち股下部1Mの横方向Yの中央部に向けて排泄されると、その排泄液は、ナプキン1の横方向Yの中央部において表面シート2、コアラップシート41を厚み方向に順次透過して吸収性コア40の肌対向面に到達し、該肌対向面上における横方向Yの中央部に存する蒸気透過抑制剤10と接触しつつ、吸収性コア40内に吸収される。図3には、こうして吸収性コア40の横方向Yの中央部に排泄液が吸収された状態が模式的に示されているところ、この吸収性コア40における排泄液吸収部45の肌対向面上には、粉末状の蒸気透過抑制剤10が該排泄液中に溶解又は分散してなる液状物11が生成され、この液状物11が排泄液由来の蒸気の表面シート2側への透過を抑制する結果として、ナプキン1の着用中のムレが抑制され、ムレに起因する肌トラブル(かゆみ、カブレ等)が効果的に防止され、また、表面シート2などの着用者の肌と接触する部材のドライ感が維持され、さらには、吸収体4に吸収された経血等の排泄液に起因する不快臭が表面シート2側に拡散する不都合も効果的に防止される。液状物11による排泄液の蒸散抑制メカニズムは定かではないが、液状物11は排泄液上に油膜が形成された層構成を有し、この油膜が、排泄液の蒸散を物理的に阻止する非透湿性バリアの役割を果たすためと推察される。尚、図3中の矢印は、排泄液由来の蒸気の透過を示し、該矢印に記号×が重ねて付された部分、即ち液状物11の存在部分は、該蒸気の透過が妨げられている、即ち蒸気の透過が完全に遮断されているか、又は液状物11の生成前に比して蒸気透過性が低下していることを示している。 The steam permeation inhibitor according to the present invention is typically powdery under normal temperature and pressure before contact with the excretory liquid, and in this state, it does not have a function of suppressing evaporation of the excretion liquid, but menstrual blood and urine. When it comes into contact with the excretory liquid such as, it dissolves or disperses in the excretion liquid and exhibits the function of suppressing the evaporation of the excretion liquid, and the water in the excretion liquid evaporates and permeates to the surface layer side and the wearer's skin side. Can be suppressed. For example, while wearing the napkin 1, when excrement fluid such as menstrual blood is excreted from the wearer's excretion portion toward the excretion portion facing portion of the crotch portion 1M, that is, the central portion of the crotch portion 1M in the lateral direction Y, the excretory fluid is excreted. The excrement liquid sequentially permeates the surface sheet 2 and the core wrap sheet 41 in the thickness direction at the central portion of the napkin 1 in the lateral direction Y, reaches the skin-facing surface of the absorbent core 40, and reaches the skin-facing surface of the absorbent core 40 in the lateral direction. It is absorbed into the absorbent core 40 while being in contact with the steam permeation inhibitor 10 existing in the central portion of Y. FIG. 3 schematically shows a state in which the excrement liquid is absorbed in the central portion of the absorbent core 40 in the lateral direction Y, and the skin-facing surface of the excrement liquid absorbing portion 45 in the absorbent core 40. On the top, a liquid substance 11 in which the powdery vapor permeation inhibitor 10 is dissolved or dispersed in the excrement liquid is generated, and the liquid substance 11 permeates the vapor derived from the excrement liquid to the surface sheet 2 side. As a result of suppressing, stuffiness during wearing of the napkin 1 is suppressed, skin troubles (itching, rash, etc.) caused by stuffiness are effectively prevented, and a member such as the surface sheet 2 that comes into contact with the wearer's skin. Furthermore, the inconvenience that the unpleasant odor caused by the excrement liquid such as menstrual blood absorbed by the absorber 4 diffuses to the surface sheet 2 side is effectively prevented. Although the mechanism for suppressing the evaporation of the excrement liquid by the liquid substance 11 is not clear, the liquid substance 11 has a layer structure in which an oil film is formed on the excrement liquid, and this oil film does not physically prevent the evaporation of the excrement liquid. It is presumed that it plays a role of a moisture permeable barrier. The arrow in FIG. 3 indicates the permeation of the vapor derived from the excrement liquid, and the portion where the symbol × is superimposed on the arrow, that is, the portion where the liquid substance 11 exists, the permeation of the vapor is hindered. That is, it indicates that the vapor permeation is completely blocked, or that the vapor permeation is reduced as compared with that before the formation of the liquid material 11.

本実施形態においては、防漏層としての裏面シート3は透湿性を有している。このため、吸収体4に吸収された排泄液由来の蒸気は、図3中矢印で示したように、裏面シート3を厚み方向に透過してナプキン1の外部へ排出されるので、液状物11によって該蒸気の表面シート2側への透過が抑制されていても、ナプキン1の内部に湿気が溜まった状態になり難く、ナプキン1の着用中のムレやそれに起因する肌トラブルがより一層効果的に防止される。 In the present embodiment, the back surface sheet 3 as the leak-proof layer has moisture permeability. Therefore, as shown by the arrow in FIG. 3, the vapor derived from the excrement liquid absorbed by the absorber 4 permeates the back surface sheet 3 in the thickness direction and is discharged to the outside of the napkin 1, so that the liquid substance 11 Even if the permeation of the vapor to the surface sheet 2 side is suppressed by this, it is difficult for moisture to accumulate inside the napkin 1, and stuffiness while wearing the napkin 1 and skin troubles caused by it are even more effective. Is prevented.

ここで「透湿性」とは、JIS Z0208やASTM E398に開示された概念の如く、気流移動を伴わず、熱力学の第二法則に従って、高湿度側から低湿度側に水蒸気拡散する性質であり、極微小の開孔を有する多孔フィルムや、水と相溶性の高い無孔フィルムで発現する性質である。透湿性を有する裏面シート3(防漏層)としては、例えば、透湿性フィルム単独、又は透湿性フィルムと不織布との積層体、撥水性不織布等を用いることができる。ナプキン1の内部に溜まった湿気(着装内湿度)を速やかに取り除く観点から、裏面シート3は、透湿性に加えてさらに、通気性を有することが好ましい。ここで「通気性」とは、文字通り通気する性質であり、典型的には各種布地のように気流が通る性質である。裏面シート3の坪量は、好ましくは18g/m2以上、さらに好ましくは35g/m2以上、そして、好ましくは100g/m2以下、さらに好ましくは80g/m2以下である。 Here, "moisture permeability" is a property of water vapor diffusing from a high humidity side to a low humidity side according to the second law of thermodynamics, without accompanying airflow movement, as in the concept disclosed in JIS Z0208 and ASTM E398. , It is a property that is exhibited in a porous film having very small pores and a non-porous film having high compatibility with water. As the back sheet 3 (leakage-proof layer) having moisture permeability, for example, a moisture-permeable film alone, a laminate of a moisture-permeable film and a non-woven fabric, a water-repellent non-woven fabric, or the like can be used. From the viewpoint of quickly removing the moisture (humidity inside the napkin 1) accumulated inside the napkin 1, the back sheet 3 preferably has breathability in addition to moisture permeability. Here, "breathability" is a property that literally ventilates, and is typically a property that airflow passes through like various fabrics. The basis weight of the back sheet 3 is preferably 18 g / m 2 or more, more preferably 35 g / m 2 or more, and preferably 100 g / m 2 or less, still more preferably 80 g / m 2 or less.

ところで、吸収体4において排泄液と蒸気透過抑制剤10との混合物たる液状物11が生成される部位は、粉末状の蒸気透過抑制剤10の存在部位であって且つ排泄液が付与された部位であり、蒸気透過抑制剤10が存していてもその蒸気透過抑制剤10が排泄液と接触せずに粉末状の形態を維持している部分、図3に示すナプキン1においては股下部1Mの横方向Yの両側部(中央部以外の部分)では、液状物11は生成されず、従って排泄液の蒸散を抑制し得る油膜は形成されない。つまり、排泄液の蒸散を抑制し得る油膜を有する液状物11は、吸収体4における排泄液吸収部45のみに選択的に生成され、排泄液が実質的に存在せず排泄液の蒸散が問題とならない部位には生成されない。このように液状物11が必要な部位にピンポイントで生成されることで、吸収体4の肌対向面側における透湿性ないし通気性を不必要に低下させずに必要十分な範囲で限定的に低下させることが可能となるため、ナプキン1の着用中のムレやそれに起因する肌トラブルがより一層効果的に防止される。 By the way, in the absorber 4, the part where the liquid substance 11 which is a mixture of the excrement liquid and the vapor permeation inhibitor 10 is generated is the part where the powdery vapor permeation inhibitor 10 exists and the part where the excrement liquid is applied. In the napkin 1 shown in FIG. 3, the crotch portion 1M is the portion where the vapor permeation inhibitor 10 is present but the vapor permeation inhibitor 10 maintains the powdery form without contacting the excrement liquid. No liquid 11 is formed on both sides (parts other than the central portion) in the lateral direction Y, and therefore an oil film capable of suppressing evaporation of the excrement liquid is not formed. That is, the liquid substance 11 having an oil film capable of suppressing the evaporation of the excrement liquid is selectively generated only in the excretion liquid absorption portion 45 in the absorber 4, and the excretion liquid does not substantially exist, and the evaporation of the excretion liquid is a problem. It is not generated in the part that does not become. By pinpointing the liquid substance 11 at the required portion in this way, the moisture permeability or air permeability on the skin-facing surface side of the absorber 4 is not unnecessarily reduced and is limited to a necessary and sufficient range. Since it can be lowered, stuffiness during wearing of the napkin 1 and skin troubles caused by the stuffiness can be prevented more effectively.

本発明の吸収性物品において、蒸気透過抑制剤は吸収層に含有されていれば良く、図2に示す蒸気透過抑制剤10のように、吸収性コア40の肌対向面とコアラップシート41との間に含有されていなくても良く、例えば、吸収性コア40内に含有されていても良く、あるいは吸収性コア40の非肌対向面(裏面シート3側の面)とコアラップシート41との間に含有されていても良い。後者の形態であっても、吸収性コア40の非肌対向面位置にて排泄液が蒸気透過抑制剤10に接触して液状物11が生成されれば、その油膜形成成分は、排泄液の大部分を占める水分よりも比重が軽いため、着用者の肌側へ自然に移行して、排泄液の蒸散を抑制し得る油膜を形成し得る。また、本実施形態を含めて前記の何れの形態においても、表面シート2と蒸気透過抑制剤10との間にコアラップシート41が介在しているため、蒸気透過抑制剤10が表面シート2側に移行しさらには着用者の肌側に飛び出す不都合が生じ難いという利点がある。 In the absorbent article of the present invention, the vapor permeation inhibitor may be contained in the absorption layer, and as in the vapor permeation inhibitor 10 shown in FIG. 2, the skin-facing surface of the absorbent core 40 and the core wrap sheet 41 It may not be contained between the two, for example, it may be contained in the absorbent core 40, or the non-skin facing surface (the surface on the back surface sheet 3 side) of the absorbent core 40 and the core wrap sheet 41. It may be contained between. Even in the latter form, if the excrement liquid comes into contact with the vapor permeation inhibitor 10 at the non-skin facing surface position of the absorbent core 40 to generate the liquid substance 11, the oil film forming component of the excrement liquid is the excrement liquid. Since it has a lighter specific gravity than the water that occupies most of it, it can naturally migrate to the skin side of the wearer and form an oil film that can suppress the evaporation of excrement. Further, in any of the above embodiments including the present embodiment, since the core wrap sheet 41 is interposed between the surface sheet 2 and the vapor permeation inhibitor 10, the vapor permeation inhibitor 10 is on the surface sheet 2 side. Furthermore, there is an advantage that the inconvenience of jumping out to the wearer's skin side is unlikely to occur.

また蒸気透過抑制剤10は、その期待される効果に鑑みれば、少なくとも吸収体4における、着用者の股間部に対向配置される股下部1M(前記排泄部対向部)に含有されていることが好ましく、吸収体4の平面視における全体に均一に含有されていることがより好ましい。吸収体4における蒸気透過抑制剤10の単位面積当たりの含有量即ち坪量は、好ましくは8g/m2以上、さらに好ましくは40g/m2以上、そして、好ましくは160g/m2以下、さらに好ましくは120g/m2以下である。 Further, in view of the expected effect, the vapor permeation inhibitor 10 is contained in at least the inseam 1M (the excretion portion facing portion) of the absorber 4 which is arranged to face the crotch portion of the wearer. It is preferable that the absorber 4 is uniformly contained in the entire surface in a plan view. The content or basis weight of the vapor permeation inhibitor 10 in the absorber 4 per unit area is preferably 8 g / m 2 or more, more preferably 40 g / m 2 or more, and preferably 160 g / m 2 or less, further preferably 160 g / m 2 or less. Is 120 g / m 2 or less.

本発明の吸収性物品において、蒸気透過抑制剤の含有量は、該吸収性物品の質量に対して、好ましくは1質量%以上、さらに好ましくは5質量%以上、そして、好ましくは20質量%以下、さらに好ましくは15質量%以下である。蒸気透過抑制剤の含有量が少なすぎるとこれを使用する意義に乏しく、蒸気透過抑制剤の含有量が多すぎると、通液性の悪化のおそれがある。 In the absorbent article of the present invention, the content of the vapor permeation inhibitor is preferably 1% by mass or more, more preferably 5% by mass or more, and preferably 20% by mass or less with respect to the mass of the absorbent article. , More preferably 15% by mass or less. If the content of the vapor permeation inhibitor is too small, there is little point in using it, and if the content of the vapor permeation inhibitor is too large, the liquid permeability may deteriorate.

本実施形態においては、図2に示すように、表面層としての表面シート2の肌対向面側が凹凸形状をなしている。本発明には、表面シート2の肌対向面側が凹凸形状をなしていない平坦面である形態も含まれるが、肌対向面側が凹凸形状をなしている表面シート2自体に排泄液の蒸散抑制効果があるため、前述した蒸気透過抑制剤10による排泄液の蒸散抑制効果と相俟って、ナプキン1の着用中のムレがより一層効果的に抑制され、これに起因する肌トラブルがより一層効果的に防止されることが期待できる。また、表面シート2の肌対向面側が凹凸形状をなしていることによって、表面シート2の肌対向面側が平坦面である場合に比して、ナプキン1の着用者の肌と表面シート2との接触面積が低減するので、表面シート2の肌対向面のドライ感が向上する。また、表面シート2の凹凸形状を構成する各凸部の内部が構成繊維で満たされていると、該凸部が中空である場合に比して、前述した表面シート2自体による排泄液の蒸散抑制効果がより確実に奏されるようになるため、好ましい。 In the present embodiment, as shown in FIG. 2, the skin-facing surface side of the surface sheet 2 as the surface layer has an uneven shape. The present invention also includes a form in which the skin-facing surface side of the surface sheet 2 is a flat surface that does not have an uneven shape, but the surface sheet 2 itself that has a skin-facing surface side that has an uneven shape has an effect of suppressing evaporation of excrement. Therefore, in combination with the above-mentioned effect of suppressing the evaporation of excrement liquid by the vapor permeation inhibitor 10, the stuffiness during wearing of the napkin 1 is suppressed more effectively, and the skin trouble caused by this is further effective. It can be expected to be prevented. Further, since the skin-facing surface side of the surface sheet 2 has an uneven shape, the skin of the wearer of the napkin 1 and the surface sheet 2 are compared with each other as compared with the case where the skin-facing surface side of the surface sheet 2 is a flat surface. Since the contact area is reduced, the dry feeling of the skin-facing surface of the surface sheet 2 is improved. Further, when the inside of each convex portion constituting the uneven shape of the surface sheet 2 is filled with the constituent fibers, the excrement liquid is evaporated by the surface sheet 2 itself as compared with the case where the convex portion is hollow. This is preferable because the suppressing effect is more reliably achieved.

表面シート2の凹凸形状は、熱エンボス加工、超音波エンボス加工等のエンボス加工によって形成することができ、そうして形成された凹凸形状を構成する各凹部即ちエンボス加工が施された部分においては、表面シート2の構成繊維が熱及び/又は圧力によって結合しており、エンボス加工が施されていない各凸部に比して高密度である。つまり、肌対向面側が凹凸形状をなしている表面シート2は、相対的に繊維密度が高い凹部と相対的に繊維密度が低い凸部とからなる繊維の粗密構造を有しているところ、斯かる繊維の粗密構造自体に排泄液の蒸散抑制効果があるため、前述した蒸気透過抑制剤10による排泄液の蒸散抑制効果と相俟って、ナプキン1の着用中のムレがより一層効果的に抑制され、これに起因する肌トラブルがより一層効果的に防止されることが期待できる。 The uneven shape of the surface sheet 2 can be formed by embossing such as thermal embossing and ultrasonic embossing, and in each recess, that is, the embossed portion, which constitutes the formed uneven shape. , The constituent fibers of the surface sheet 2 are bonded by heat and / or pressure, and the density is higher than that of each convex portion which is not embossed. That is, the surface sheet 2 having a concave-convex shape on the side facing the skin has a coarse-dense structure of fibers composed of concave portions having a relatively high fiber density and convex portions having a relatively low fiber density. Since the coarse fiber structure itself has the effect of suppressing the transpiration of the excrement liquid, the stuffiness during wearing of the napkin 1 is even more effective in combination with the above-mentioned effect of suppressing the transpiration of the excrement liquid by the steam permeation inhibitor 10. It is expected that it will be suppressed and skin troubles caused by this will be prevented even more effectively.

表面シート2(表面層)としては、この種の吸収性物品において従来用いられている液透過性の表面シートを用いることができ、例えば、カード法により製造された不織布、エアスルー不織布、スパンボンド不織布、メルトブローン不織布、スパンレース不織布及びニードルパンチ不織布等の種々の不織布;開口手段によって液透過可能とされたフィルム等が挙げられる。これらの不織布やフィルムには、界面活性剤等の親水化剤を用いた親水化処理が施されていても良い。表面シート2の坪量は、好ましくは20g/m2以上、さらに好ましくは35g/m2以上、そして、好ましくは100g/m2以下、さらに好ましくは80g/m2以下である。 As the surface sheet 2 (surface layer), a liquid-permeable surface sheet conventionally used in this type of absorbent article can be used. For example, a non-woven fabric, an air-through non-woven fabric, or a spunbonded non-woven fabric manufactured by the card method can be used. , Melt blown non-woven fabric, spun lace non-woven fabric, needle punch non-woven fabric, and other non-woven fabrics; films made liquid permeable by opening means and the like can be mentioned. These non-woven fabrics and films may be hydrophilized with a hydrophilic agent such as a surfactant. The basis weight of the surface sheet 2 is preferably 20 g / m 2 or more, more preferably 35 g / m 2 or more, and preferably 100 g / m 2 or less, still more preferably 80 g / m 2 or less.

以下、本発明に係る蒸気透過抑制剤について説明する。本発明に係る蒸気透過抑制剤は、前述した通り、経血、尿等の排泄液中に溶解又は分散して該排泄液上に油膜を形成する油膜形成剤とも言えるもので、油分、乳化剤及びゲル化剤を含有し、典型的には、常温常圧下において粉末状である。本発明に係る蒸気透過抑制剤としては、常温常圧下において粉末状のものが、肌に付着し難くべたつき難いため好ましい。 Hereinafter, the vapor permeation inhibitor according to the present invention will be described. As described above, the vapor permeation inhibitor according to the present invention can be said to be an oil film forming agent that dissolves or disperses in excrement liquid such as menstrual blood and urine to form an oil film on the excretion liquid, and can be said to be an oil component, an emulsifier and It contains a gelling agent and is typically in the form of a powder under normal temperature and pressure. As the vapor permeation inhibitor according to the present invention, a powdery one under normal temperature and pressure is preferable because it does not easily adhere to the skin and is not sticky.

蒸気透過抑制剤に含まれる油分としては、例えば、なたね油、コーン油、綿実油、オリーブオイル、ごま油等の食用油;グリセリン等の多価アルコールが挙げられ、これらの1種を単独で又は2種以上を組み合わせて用いることができる。蒸気透過抑制剤は、このような食用油や多価アルコールを主体とするものであり、人体に対する安全性が高いものである。 Examples of the oil contained in the steam permeation inhibitor include edible oils such as rapeseed oil, corn oil, cottonseed oil, olive oil and sesame oil; and polyhydric alcohols such as glycerin, and one of these may be used alone or in combination of two or more. Can be used in combination. The vapor permeation inhibitor is mainly composed of such cooking oil and polyhydric alcohol, and is highly safe for the human body.

蒸気透過抑制剤における油分の含有量は、蒸気透過抑制剤に対して、好ましくは50質量%以上、さらに好ましくは70質量%以上、そして、好ましくは95質量%以下、さらに好ましくは90質量%以下である。蒸気透過抑制剤において油分の含有量が少なすぎると、排泄液由来の蒸気の表面シート側への透過抑制効果が低下するおそれがあり、逆に油分の含有量が多すぎると、相対的に乳化剤及びゲル化剤の含有量が少なくなって好ましくない。 The oil content of the vapor permeation inhibitor is preferably 50% by mass or more, more preferably 70% by mass or more, and preferably 95% by mass or less, still more preferably 90% by mass or less, based on the vapor permeation inhibitor. Is. If the oil content of the vapor permeation inhibitor is too low, the effect of suppressing the permeation of the vapor derived from the excrement liquid to the surface sheet side may decrease, and conversely, if the oil content is too high, it is a relatively emulsifier. And the content of the gelling agent is low, which is not preferable.

蒸気透過抑制剤に含まれる乳化剤としては、HLB(親水性−親油性バランス)が8以上13以下のO/W型エマルションが好ましい。この特定のO/W型エマルションを乳化剤として用いることで、常温常圧下において粉末状の蒸気透過抑制剤が得られやすくなる。この特定のO/W型エマルションの乳化剤としては、例えば、グリセリン脂肪酸エステル、ソルビタン脂肪酸エステル、ショ糖脂肪酸エステル、プロピレングリコール脂肪酸エステル、大豆リン脂質等が挙げられ、これらの1種を単独で又は2種以上を組み合わせて用いることができる。 As the emulsifier contained in the vapor permeation inhibitor, an O / W type emulsion having an HLB (hydrophilic-lipophilic balance) of 8 or more and 13 or less is preferable. By using this specific O / W type emulsion as an emulsifier, it becomes easy to obtain a powdery vapor permeation inhibitor under normal temperature and pressure. Examples of the emulsifier of this specific O / W type emulsion include glycerin fatty acid ester, sorbitan fatty acid ester, sucrose fatty acid ester, propylene glycol fatty acid ester, soybean phospholipid, and the like, and one of them alone or 2 A combination of seeds and above can be used.

蒸気透過抑制剤における乳化剤の含有量は、蒸気透過抑制剤に対して、好ましくは0.5質量%以上、さらに好ましくは1質量%以上、そして、好ましくは5質量%以下、さらに好ましくは3質量%以下である。蒸気透過抑制剤において乳化剤の含有量が多すぎても少なすぎても、常温常圧下において粉末状の蒸気透過抑制剤が得られにくくなるおそれがある。
また同様の観点から、蒸気透過抑制剤における乳化剤の含有量は、蒸気透過抑制剤中の油分に対して、好ましくは0.5質量%以上、さらに好ましくは1質量%以上、そして、好ましくは10質量%以下、さらに好ましくは5質量%以下である。
The content of the emulsifier in the vapor permeation inhibitor is preferably 0.5% by mass or more, more preferably 1% by mass or more, and preferably 5% by mass or less, still more preferably 3% by mass, based on the vapor permeation inhibitor. % Or less. If the content of the emulsifier in the vapor permeation inhibitor is too high or too low, it may be difficult to obtain a powdery vapor permeation inhibitor under normal temperature and pressure.
From the same viewpoint, the content of the emulsifier in the vapor permeation inhibitor is preferably 0.5% by mass or more, more preferably 1% by mass or more, and preferably 10 with respect to the oil content in the vapor permeation inhibitor. It is mass% or less, more preferably 5 mass% or less.

蒸気透過抑制剤に含まれるゲル化剤としては、雰囲気温度40℃以下において水に溶ける性質を有するものが好ましい。ここでいう、「雰囲気温度40℃以下において水に溶ける性質」とは、40℃の水に対する溶解度が0.5g以上あることを意味し、斯かる溶解度が1g以上であると、ムレ等をより一層防止し得るため好ましい。この雰囲気温度40℃というのは、着用中の吸収性物品の内部空間(着用者の肌と吸収性物品の肌対向面との間)の雰囲気温度あるいは着用者の体温に近い温度であるところ、ゲル化剤がこのような体温程度の雰囲気において水に対する溶解性を示すことで、吸収性物品の着用時に経血、尿等の排泄液と接触したときに速やかに排泄液中に溶解又は分散し得るようになる。斯かる性質を有するゲル化剤としては、例えば、寒天、ゼラチン、カラギーナン、ペクチン等が挙げられ、これらの1種を単独で又は2種以上を組み合わせて用いることができる。 As the gelling agent contained in the vapor permeation inhibitor, one having a property of being soluble in water at an atmospheric temperature of 40 ° C. or lower is preferable. Here, the "property of being soluble in water at an atmospheric temperature of 40 ° C. or lower" means that the solubility in water at 40 ° C. is 0.5 g or more, and when such a solubility is 1 g or more, stuffiness or the like is further increased. It is preferable because it can be further prevented. The atmospheric temperature of 40 ° C. is a temperature close to the atmospheric temperature of the internal space of the absorbent article during wearing (between the skin of the wearer and the surface of the absorbent article facing the skin) or the body temperature of the wearer. Since the gelling agent shows solubility in water in such an atmosphere of body temperature, it quickly dissolves or disperses in the excrement liquid when it comes into contact with excrement liquid such as menstrual blood and urine when wearing an absorbent article. You will get it. Examples of the gelling agent having such properties include agar, gelatin, carrageenan, pectin and the like, and one of these can be used alone or in combination of two or more.

蒸気透過抑制剤におけるゲル化剤の含有量は、蒸気透過抑制剤に対して、好ましくは5質量%以上、さらに好ましくは7質量%以上、そして、好ましくは20質量%以下、さらに好ましくは15量%以下である。蒸気透過抑制剤においてゲル化剤の含有量が多すぎても少なすぎても、常温常圧下において粉末状の蒸気透過抑制剤が得られにくくなるおそれがある。
また同様の観点から、蒸気透過抑制剤におけるゲル化剤の含有量は、蒸気透過抑制剤中の油分に対して、好ましくは5質量%以上、さらに好ましくは7質量%以上、そして、好ましくは20質量%以下、さらに好ましくは15質量%以下である。
The content of the gelling agent in the vapor permeation inhibitor is preferably 5% by mass or more, more preferably 7% by mass or more, and preferably 20% by mass or less, still more preferably 15% by mass, based on the vapor permeation inhibitor. % Or less. If the content of the gelling agent in the vapor permeation inhibitor is too high or too low, it may be difficult to obtain a powdery vapor permeation inhibitor under normal temperature and pressure.
From the same viewpoint, the content of the gelling agent in the vapor permeation inhibitor is preferably 5% by mass or more, more preferably 7% by mass or more, and preferably 20% by mass, based on the oil content in the vapor permeation inhibitor. It is mass% or less, more preferably 15 mass% or less.

常温常圧下において粉末状の蒸気透過抑制剤は、油分、乳化剤及びゲル化剤の液状混合物を乾燥して固体粉末状にすることで得られる。より具体的には、例えば、水とゲル化剤とを混合し、その混合物の温度が80℃程度になる条件でこれを加熱しつつ攪拌し、水とゲル化剤との混合物におけるゲル化剤の濃度は、通常1〜5質量%程度である。その攪拌中の混合物に乳化剤と油分とをこの順で添加し、さらに攪拌して、水を連続相とする水中油滴(O/W)型の液状混合物を得る。そしてこの液状混合物を、凍結乾燥、噴霧乾燥等の公知の乾燥方法に付し、必要に応じ乾燥後の固形物を粉砕処理することで、目的とする粉末状の蒸気透過抑制剤(油膜形成剤)が得られる。水とゲル化剤との混合物におけるゲル化剤に対して、該混合物中の油分の濃度は約10質量%程度、該混合物中の乳化剤の濃度は0.2質量%程度である。こうして得られた粉末状の蒸気透過抑制剤における各粉末粒子には、内側から順に、油分、乳化剤、ゲル化剤が存在している。 The vapor permeation inhibitor in powder form under normal temperature and pressure is obtained by drying a liquid mixture of an oil component, an emulsifier and a gelling agent into a solid powder. More specifically, for example, water and a gelling agent are mixed, and the mixture is stirred while heating under the condition that the temperature of the mixture becomes about 80 ° C., and the gelling agent in the mixture of water and the gelling agent. The concentration of is usually about 1 to 5% by mass. An emulsifier and an oil component are added to the stirring mixture in this order, and the mixture is further stirred to obtain an oil droplet (O / W) type liquid mixture in water having water as a continuous phase. Then, this liquid mixture is subjected to a known drying method such as freeze-drying or spray-drying, and the solid matter after drying is pulverized as necessary to obtain a desired powdery vapor permeation inhibitor (oil film forming agent). ) Is obtained. The concentration of the oil content in the mixture is about 10% by mass, and the concentration of the emulsifier in the mixture is about 0.2% by mass with respect to the gelling agent in the mixture of water and the gelling agent. Oil, an emulsifier, and a gelling agent are present in each of the powder particles in the powdered vapor permeation inhibitor thus obtained in this order from the inside.

以上、本発明をその好ましい実施形態に基づき説明したが、本発明は前記実施形態に制限されない。例えばナプキン1において、表面シート2と吸収体4(コアラップシート41)との間に、セカンドシートあるいはサブレイヤーシートなどとも呼ばれる液透過性シートが介在されていても良い。また本発明の吸収性物品には、生理用ナプキンの他、パンティライナ(おりものシート)、失禁パッド、使い捨ておむつ等、経血や尿等の排泄液の吸収用途に使用可能な物品が含まれる。 Although the present invention has been described above based on the preferred embodiment, the present invention is not limited to the above embodiment. For example, in the napkin 1, a liquid permeable sheet, which is also called a second sheet or a sublayer sheet, may be interposed between the surface sheet 2 and the absorber 4 (core wrap sheet 41). In addition to sanitary napkins, the absorbent articles of the present invention include pantyliners, incontinence pads, disposable diapers, and other articles that can be used to absorb excrement such as menstrual blood and urine. ..

以下、本発明を実施例により更に具体的に説明するが、本発明は斯かる実施例に限定されるものではない。 Hereinafter, the present invention will be described in more detail with reference to Examples, but the present invention is not limited to such Examples.

(蒸気透過抑制剤Aの製造)
イオン交換水89質量部と、ゲル化剤として寒天1質量部とを、ホモミキサーに投入・混合し、その混合物の温度が80℃になる条件でこれを加熱しつつ攪拌し、さらにその攪拌中の混合物に、乳化剤としてHLB9のグリセリン脂肪酸エステル(太陽化学株式会社製、商品名「サンソフトNo.641D」)0.2質量部と、油分としてなたね油10質量部とを、この順で添加した後、該混合物の温度80℃が維持されるように加熱しつつ回転数8000rpmで5分間攪拌した。こうして得られたO/W型の液状混合物を凍結乾燥し粉末状の蒸気透過抑制剤Aを製造した。
(Manufacturing of vapor permeation inhibitor A)
89 parts by mass of ion-exchanged water and 1 part by mass of agar as a gelling agent are put into a homomixer and mixed, and the mixture is stirred while heating under the condition that the temperature of the mixture becomes 80 ° C. After adding 0.2 parts by mass of HLB9 glycerin fatty acid ester (manufactured by Taiyo Kagaku Co., Ltd., trade name "Sunsoft No. 641D") as an emulsifier and 10 parts by mass of rapeseed oil as an oil to the mixture of the above in this order. The mixture was stirred at a rotation speed of 8000 rpm for 5 minutes while heating so that the temperature of the mixture was maintained at 80 ° C. The O / W type liquid mixture thus obtained was freeze-dried to produce a powdery vapor permeation inhibitor A.

(蒸気透過抑制剤Bの製造)
油分、乳化剤及びゲル化剤の使用量を変更すると共に、乳化剤としてHLB13のグリセリン脂肪酸エステル(太陽化学株式会社製、商品名「サンソフトA−181E」)を使用した以外は、前記(蒸気透過抑制剤Aの製造)と同様にして、蒸気透過抑制剤Bを製造した。
(Manufacturing of vapor permeation inhibitor B)
The above (steam permeation suppression) except that the amount of oil, emulsifier and gelling agent used was changed and HLB13 glycerin fatty acid ester (manufactured by Taiyo Kagaku Co., Ltd., trade name "Sunsoft A-181E") was used as the emulsifier. The steam permeation inhibitor B was produced in the same manner as in the production of the agent A).

〔試験例1〜2:蒸気透過抑制剤の評価試験〕
室温23℃、50%R.H.の環境下で、馬血の血漿10gが入ったシャーレに評価対象の蒸気透過抑制剤を1g投入し、その剤投入直後から1時間経過ごとにシャーレの総重量を測定し、剤投入前の総重量を基準として血漿の減少量を算出した。血漿は前記環境下で徐々に蒸散するところ、評価対象の蒸気透過抑制剤が蒸散抑制機能を有していれば血漿の蒸散が抑制されるので、血漿の減少量は少なくなる。対照例として、蒸気透過抑制剤が投入されずに馬血の血漿10gのみが入ったシャーレを用意し、その対照についても血漿の減少量を測定した。結果を下記表1に示す。
[Test Examples 1 and 2: Evaluation test of vapor permeation inhibitor]
Room temperature 23 ° C., 50% R. H. In this environment, 1 g of the vapor permeation inhibitor to be evaluated was added to the petri dish containing 10 g of horse blood plasma, and the total weight of the petri dish was measured every hour immediately after the agent was added, and the total weight before the agent was added. The amount of plasma loss was calculated based on the weight. When plasma is gradually transpired in the above environment, if the vapor permeation inhibitor to be evaluated has an evaporation suppressing function, plasma evaporation is suppressed, so that the amount of plasma reduction is small. As a control example, a petri dish containing only 10 g of horse blood plasma without adding a vapor permeation inhibitor was prepared, and the amount of plasma reduction was also measured for the control. The results are shown in Table 1 below.

Figure 0006869653
Figure 0006869653

表1に示す通り、試験例1及び2は対照例に比して血漿の減少量が少ないことから、蒸気透過抑制剤A及びBが蒸散抑制機能(油膜形成能)を有していることが明らかである。従って、吸収性物品における吸収層にこのような蒸散抑制機能を有する蒸気透過抑制剤が含有されていることで、その吸収性物品の着用中において排泄液の蒸散が抑制され、ムレや肌トラブルが効果的に防止され得ることが理解できる。 As shown in Table 1, since the amount of plasma decreased in Test Examples 1 and 2 was smaller than that in the control example, the vapor permeation inhibitors A and B had a transpiration inhibitory function (oil film forming ability). it is obvious. Therefore, since the absorbent layer of the absorbent article contains a vapor permeation inhibitor having such an evaporation suppressing function, the evaporation of excrement liquid is suppressed while the absorbent article is worn, causing stuffiness and skin troubles. It can be understood that it can be effectively prevented.

1 生理用ナプキン(吸収性物品)
2 表面シート(表面層)
3 裏面シート(防漏層)
4 吸収体(吸収層)
40 吸収性コア
41 コアラップシート
45 排泄液吸収部
5 吸収性本体
10 蒸気透過抑制剤
11 蒸気透過抑制剤の液状物
1 Sanitary napkin (absorbent article)
2 Surface sheet (surface layer)
3 Back sheet (leakage-proof layer)
4 Absorber (absorbent layer)
40 Absorbent core 41 Core wrap sheet 45 Excretion absorber 5 Absorbent body 10 Vapor permeation inhibitor 11 Liquid substance of vapor permeation inhibitor

Claims (6)

肌対向面を形成する液透過性の表面層、非肌対向面を形成する液不透過性の防漏層、及び両層間に介在され、着用者の排泄液を吸収する吸収層を具備する吸収性物品であって、
前記吸収層は、吸収性材料を含有する吸収性コアと、該吸収性コアの肌対向面を被覆するコアラップシートとを含んで構成され、且つ蒸気透過抑制剤を含有し、
前記蒸気透過抑制剤は、油分、乳化剤及びゲル化剤を含有し、且つ前記吸収性コアの肌対向面と前記コアラップシートとの間における、着用者の股間部に対向配置される部分に存している吸収性物品。
Absorption provided with a liquid-permeable surface layer forming a skin-facing surface, a liquid-impermeable leak-proof layer forming a non-skin-facing surface, and an absorption layer interposed between the two layers to absorb the wearer's excrement. It ’s a sex item,
The absorbent layer is composed of an absorbent core containing an absorbent material and a core wrap sheet covering the skin-facing surface of the absorbent core, and also contains a vapor permeation inhibitor.
The vapor permeation inhibitor is contained in an oil, an emulsifier and a gelling agent, and is located in a portion of the absorbent core facing the skin and facing the core wrap sheet so as to face the wearer's crotch. intake Osamusei goods it is.
前記乳化剤は、HLBが8以上13以下のO/W型エマルションである請求項1に記載の吸収性物品。 The absorbable article according to claim 1, wherein the emulsifier is an O / W type emulsion having an HLB of 8 or more and 13 or less. 前記ゲル化剤は、雰囲気温度40℃以下において水に溶ける性質を有する請求項1又は2に記載の吸収性物品。 The absorbent article according to claim 1 or 2, wherein the gelling agent has a property of being soluble in water at an atmospheric temperature of 40 ° C. or lower. 前記蒸気透過抑制剤は、該蒸気透過抑制剤中の前記油分に対して、前記乳化剤を0.5質量%以上10質量%以下、前記ゲル化剤を5質量%以上20質量%以下含有する請求項1〜3の何れか1項に記載の吸収性物品。 The vapor permeation inhibitor contains 0.5% by mass or more and 10% by mass or less of the emulsifier and 5% by mass or more and 20% by mass or less of the gelling agent with respect to the oil content in the vapor permeation inhibitor. Item 2. The absorbent article according to any one of Items 1 to 3. 前記蒸気透過抑制剤の含有量は、前記吸収性物品の質量に対して1質量%以上20質量%以下である請求項1〜4の何れか1項に記載の吸収性物品。 The absorbent article according to any one of claims 1 to 4, wherein the content of the vapor permeation inhibitor is 1% by mass or more and 20% by mass or less with respect to the mass of the absorbent article. 前記防漏層は透湿性を有する請求項1〜5の何れか1項に記載の吸収性物品。 The absorbent article according to any one of claims 1 to 5, wherein the leak-proof layer has moisture permeability.
JP2016131417A 2016-07-01 2016-07-01 Absorbent article Active JP6869653B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2016131417A JP6869653B2 (en) 2016-07-01 2016-07-01 Absorbent article

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2016131417A JP6869653B2 (en) 2016-07-01 2016-07-01 Absorbent article

Publications (2)

Publication Number Publication Date
JP2018000546A JP2018000546A (en) 2018-01-11
JP6869653B2 true JP6869653B2 (en) 2021-05-12

Family

ID=60945379

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016131417A Active JP6869653B2 (en) 2016-07-01 2016-07-01 Absorbent article

Country Status (1)

Country Link
JP (1) JP6869653B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7370151B2 (en) * 2019-03-27 2023-10-27 大王製紙株式会社 disposable diapers
JP7289689B2 (en) * 2019-03-27 2023-06-12 大王製紙株式会社 Tape type disposable diaper

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3769239B2 (en) * 2001-08-31 2006-04-19 ハウス食品株式会社 Seasoning for fried food and method for producing the same
JP2004089322A (en) * 2002-08-30 2004-03-25 Crecia Corp Absorbent article
JP5420952B2 (en) * 2009-03-31 2014-02-19 大王製紙株式会社 Absorbent articles
JP6172809B2 (en) * 2013-12-03 2017-08-02 花王株式会社 Absorbent articles

Also Published As

Publication number Publication date
JP2018000546A (en) 2018-01-11

Similar Documents

Publication Publication Date Title
JP6392311B2 (en) Absorbent assembly and disposable absorbent underwear
US8178746B2 (en) Delivery device
US20030093045A1 (en) Absorbing article having zoned areas of hydrophilicity
KR101944579B1 (en) Absorbent article
JP6184670B2 (en) Absorber and absorbent article using the same
BR112018009919B1 (en) Non-woven take-up distribution layer and absorbent article
TW201127347A (en) Absorbent article
JP2017506991A (en) Absorbent pads with areas of different absorbent performance
JP6850580B2 (en) Absorbent article
JP4317363B2 (en) Absorbent products including leak barriers
JP4800393B2 (en) Absorbent article
JP4130157B2 (en) Absorbent articles
JP6869653B2 (en) Absorbent article
JPH10502550A (en) Absorbent article having cushioning member and barrier
JP2003235892A (en) Throw-away diaper
JP6715811B2 (en) Absorbent article
JP6245916B2 (en) Absorbent articles
JP6418826B2 (en) Water-absorbing layer manufacturing method, water-absorbing layer and absorbent article provided with the same
JP6872946B2 (en) Absorbent article
JP2022093954A (en) Disposable diaper
JP2018068911A (en) Absorbent article
JP2018050869A (en) Absorbent article
JP2009254662A (en) Absorbent article
WO2019107192A1 (en) Absorbent article
JP2018508250A (en) Absorbent products including non-woven materials

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190603

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20200319

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200602

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200727

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20201208

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201208

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20210323

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20210414

R151 Written notification of patent or utility model registration

Ref document number: 6869653

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R151

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250